13 reactions | 45 years ago, Biogen began with the mission to provide...
0:08
13 reactions | 45 years ago, Biogen began with the mission to provide...
2K views6 days ago
FacebookBiogen
Clinical Trials | Biogen
Clinical Trials | Biogen
Nov 15, 2022
biogen.com
Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaborat…
Feb 18, 2025
finanznachrichten.de
15K views | We’re evolving and diversifying our pipeline. Learn about our focus in immunology, neurology and rare disease. | Biogen | Facebook
0:33
15K views | We’re evolving and diversifying our pipeline. Learn ab…
7.3K views2 weeks ago
FacebookBiogen
Biogen to invest $2 billion in RTP, open new factory in 2025
Biogen to invest $2 billion in RTP, open new factory in 2025
7 months ago
wral.com
Biogen expanding to keep pace with modernization, artificial intelligence
Biogen expanding to keep pace with modernization, artificial intelligence
7 months ago
washingtonexaminer.com
Transcript : Biogen Inc. Presents at Wedbush Rewind ASN 2025 Conference, Nov-10-2025 11
Transcript : Biogen Inc. Presents at Wedbush Rewind ASN 2025 Confe…
3 months ago
zonebourse.com
Biogen Inc.: Biogen Announces Late Breaker and New Data Presentatio…
Oct 22, 2024
finanznachrichten.de
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
6 months ago
finanznachrichten.de
Biogen's Litifilimab Receives FDA Breakthrough Therapy Designatio…
1 month ago
marketscreener.com
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
8 months ago
finanznachrichten.de
Biogen Gets U.S., European Reviews of Higher-Dose Spinraza
Jan 23, 2025
marketscreener.com
0:43
We believe that no other disease area holds as much need or promi…
8.7K viewsDec 7, 2018
FacebookBiogen
In dramatic turn, Biogen seeks FDA approval for experimental Alzheim…
Oct 22, 2019
goodmorningamerica.com
Biogen | LinkedIn
11 months ago
linkedin.com
Biogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Tre…
8 months ago
finanznachrichten.de
Biogen Inc.: LEQEMBI IQLIK(lecanemab-irmb) Subcutane…
4 months ago
finanznachrichten.de
1:02
133 reactions · 67 shares | Today marks a historic day in Biogen’s c…
5.2K views1 month ago
FacebookBiogen
1:32
U.S. approval of Biogen Alzheimer's drug sends shares soaring, haile…
Jun 7, 2021
ReutersJulie Steenhuysen,Deena Beasley
Stories | Biogen
Nov 15, 2022
biogen.com
0:47
Biogen Alzheimer's drug closer to approval with U.S. FDA staff backi…
Nov 5, 2020
ReutersDeena Beasley,Manojna Maddipatla
Careers | Biogen
Aug 2, 2018
biogen.com
US FDA approves Eisai, Biogen Alzheimer's drug
Jan 6, 2023
gmanetwork.com
Biogen Inc.: LEQEMBI (lecanemab) IV Maintenance Dosing for the Tre…
4 months ago
finanznachrichten.de
Is Biogen At The 'Start Of A Turnaround' On Its Q1 Beat?
10 months ago
investors.com
Biogen Inc.: Biogen to Acquire Alcyone Therapeutics, Expanding …
5 months ago
finanznachrichten.de
2:32
We are pioneers in neuroscience. We are Biogen.
2.6K viewsNov 26, 2019
YouTubeBiogen
Biogen Inc.: Biogen and Stoke Therapeutics Present Data at the 3…
Feb 9, 2025
finanznachrichten.de
Biogen Licenses Global Rights To Develop, Commercialize SPINRAZ…
Jan 4, 2022
nasdaq.com
See more videos
Static thumbnail place holder